Two doses of Covishield effectively protected above-45 population from infection: Study - The Indian Express

The vaccination coverage among the eligible population (18+) began picking up rapidly last year and by May 22, 2021, about 20 per cent of individuals of 45 years of age or above had received both doses of the Covid-19 vaccine.

A new study by the National Institute of Epidemiology, Chennai, and National Institute of Virology, Pune, has demonstrated the effectiveness of two doses of Covishield (ChAdOx1) vaccine against the D… [+3094 chars]

full article...